Technical Analysis for INSY - Insys Therapeutics, Inc.
|Grade||Last Price||% Change||Price Change|
INSY closed up 0.26 percent on Friday, October 20, 2017, on 73 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: Nov 2
|See historical INSY trend table...|
|Date||Alert Name||Type||% Chg|
|Oct 20||Narrow Range Bar||Range Contraction||0.00%|
|Oct 20||Non-ADX 1,2,3,4 Bearish||Bearish Swing Setup||0.00%|
|Oct 19||NR7||Range Contraction||0.26%|
|Oct 19||NR7-2||Range Contraction||0.26%|
|Oct 19||Narrow Range Bar||Range Contraction||0.26%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
INSYS Therapeutics, Inc., a development stage company, develops pharmaceutical products that target the unmet needs of cancer patients, with a focus on cancer-supportive care. The company's cancer-supportive care and cancer therapy product candidates include Fentanyl sublingual spray, a single-use product for the treatment of breakthrough cancer pain; and Dronabinol SG capsule, an ANDA approved product and Dronabinol Oral Solution, which completed Phase II clinical trials for the treatment of chemotherapy-induced nausea and vomiting, and appetite stimulation in AIDS patients. It also develops proprietary cancer therapeutics comprising LEP-ETU, a NeoLipid liposomal, which is in Phase II clinical development stage to enhance efficacy and reduce paclitaxel-related side effects. The company was founded in 2002 and is based in Phoenix, Arizona.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more INSY news...
|52 Week High||15.06|
|52 Week Low||7.27|
|200-Day Moving Average||10.7482|
|50-Day Moving Average||8.9301|
|20-Day Moving Average||8.4478|
|10-Day Moving Average||7.772|
|Average True Range||0.4137|
|Chandelier Exit (Long, 3 ATRs )||9.0689|
|Chandelier Exit (Short, 3 ATRs )||8.5111|
|Upper Bollinger Band||9.9779|
|Lower Bollinger Band||6.9177|
|Percent B (%b)||0.23|
|MACD Signal Line||-0.4031|
|Market Cap||553.22 Million|
|Num Shares||72.7 Million|
|Price-to-Earnings (P/E) Ratio||-34.59|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||7.88|
|Resistance 3 (R3)||7.89||7.81||7.84|
|Resistance 2 (R2)||7.81||7.74||7.81||7.82|
|Resistance 1 (R1)||7.71||7.70||7.70||7.70||7.80|
|Support 1 (S1)||7.53||7.56||7.52||7.52||7.42|
|Support 2 (S2)||7.45||7.52||7.45||7.40|
|Support 3 (S3)||7.35||7.45||7.39|
|Support 4 (S4)||7.34|